ZG-5266

奥贝胆酸镁

Report date: 2024/03/19 20:00:40

Base Information

Drug NameZG-5266
Drug Alias NameZG-5266
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBile acid receptor FXR agonists
TargetsBile acid receptor FXR
Therapy Area/IndicationsCholangitis, Sclerosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesSuzhou Zelgen Biopharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSuzhou Zelgen Biopharmaceuticals Co Ltd
Active IndicationsN/A
Inactive IndicationsCholangitis, Sclerosing

Other Information

ATC CodeN/A
Related LinksN/A